Literature DB >> 34264100

Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh.

Mokibul Hassan Afrad1, Manjur Hossain Khan2, Sadia Isfat Ara Rahman1, Omar Hamza Bin Manjur3, Mohabbat Hossain3, Ahmed Nawsher Alam2, Farzana Islam Khan2, Nawroz Afreen2, Farsim Tarannum Haque2, Nicholas R Thomson4,5, Tahmina Shirin2, Firdausi Qadri1,3.   

Abstract

We report the coding-complete genome sequences of 15 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sublineage B.1.617.2 strains that were obtained from Bangladeshi individuals with a history of recent travel to India and from the Bangladeshi community. Genomic data were generated by Nanopore sequencing using the amplicon sequencing approach developed by the ARTIC Network.

Entities:  

Year:  2021        PMID： 34264100     DOI： 10.1128/MRA.00560-21

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN： 2576-098X


  4 in total

Review 1.  B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies.

Authors:  Yan Zhan; Hui Yin; Ji-Ye Yin
Journal:  Int J Biol Sci       Date:  2022-02-14       Impact factor: 6.580

2.  Transmission Dynamics and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in Bangladesh.

Authors:  Md Abu Sayeed; Jinnat Ferdous; Otun Saha; Shariful Islam; Shusmita Dutta Choudhury; Josefina Abedin; Mohammad Mahmudul Hassan; Ariful Islam
Journal:  Trop Med Infect Dis       Date:  2022-08-20

3.  NanoCoV19: An analytical pipeline for rapid detection of severe acute respiratory syndrome coronavirus 2.

Authors:  Jidong Lang
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

4.  Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.

Authors:  Taufiqur Rahman Bhuiyan; Hasan Al Banna; M Hasanul Kaisar; Polash Chandra Karmakar; Al Hakim; Afroza Akter; Tasnuva Ahmed; Imam Tauheed; Shaumik Islam; Mohammad Abul Hasnat; Mostafa Aziz Sumon; Asif Rashed; Shuvro Ghosh; John D Clemens; Sayera Banu; Tahmina Shirin; Daniela Weiskopf; Alessandro Sette; Fahima Chowdhury; Firdausi Qadri
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.